SPONSOR
Boston University Charles River Campus
Total Trials
6
Recruiting
6
Phases
N/A
Conditions studied: First Episode Psychosis (FEP)Parkinson's Disease (PD)Essential TremorEpilepsy IntractableSocial Anxiety DisorderAlzheimer DiseaseAlzheimer Disease (AD)Mild Cognitive Impairment (MCI)
Boston University Charles River Campus is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including First Episode Psychosis (FEP), Parkinson's Disease (PD), Essential Tremor, Epilepsy Intractable.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Boston University Charles River Campus
How many clinical trials has Boston University Charles River Campus sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Boston University Charles River Campus, of which 6 are actively recruiting participants. These trials cover conditions including First Episode Psychosis (FEP), Parkinson's Disease (PD), Essential Tremor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Boston University Charles River Campus research focus on?
Boston University Charles River Campus clinical trials span First Episode Psychosis (FEP), Parkinson's Disease (PD), Essential Tremor, Epilepsy Intractable, Social Anxiety Disorder, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Boston University Charles River Campus clinical trial?
To participate in a Boston University Charles River Campus trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Boston University Charles River Campus trials with current recruitment status updated daily.
Clinical Trials by Boston University Charles River Campus
NCT07749105
Recruiting
Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies
First Episode Psychosis (FEP)
NCT07455760
Recruiting
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
Parkinson's Disease (PD)
NCT05406349
Recruiting
Neural Mechanisms of Spatial Representations Beyond the Self
Epilepsy Intractable
NCT05683223
Recruiting
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Social Anxiety Disorder
NCT06094192
Recruiting
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
Alzheimer Disease
NCT07659964
Recruiting
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
Alzheimer Disease (AD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology